血脂在缺血性卒中及其亚型发展中的作用:一项孟德尔随机化研究
该研究利用185个全基因组脂质相关单核苷酸多态性,通过孟德尔随机化分析血脂对缺血性卒中及其亚型的因果作用。结果显示遗传升高的LDL胆固醇与缺血性卒中及大动脉粥样硬化性卒中风险增加相关,遗传升高的HDL胆固醇与小动脉闭塞性卒中风险降低相关,甘油三酯无显著关联。
要点
- 遗传升高的LDL胆固醇增加缺血性卒中及大动脉粥样硬化性卒中风险。
- 遗传升高的HDL胆固醇降低小动脉闭塞性卒中风险。
- 遗传升高的甘油三酯与缺血性卒中及其亚型无显著关联。
核心结论
- 降低LDL胆固醇可能预防大动脉粥样硬化性卒中,但可能不能预防小动脉闭塞性卒中和心源性栓塞性卒中。
- 升高HDL胆固醇可能对小动脉疾病预防有益。
- 降低甘油三酯可能不会对缺血性卒中及其亚型产生益处。
研究设计与样本
- 孟德尔随机化研究,获取185个全基因组脂质相关单核苷酸多态性的汇总数据,来自全球脂质遗传学联盟和卒中遗传学网络。
- 缺血性卒中样本包括16851例病例和32473例对照,亚型包括大动脉粥样硬化(2410例)、小动脉闭塞(3186例)和心源性栓塞(3427例)。
主要发现
- 遗传升高的LDL胆固醇每1-SD与缺血性卒中风险增加相关(OR 1.12;95%CI 1.04-1.20),与大动脉粥样硬化性卒中风险增加相关(OR 1.28;95%CI 1.10-1.49),与小动脉闭塞或心源性栓塞性卒中无显著关联(多变量MR)。
- 遗传升高的HDL胆固醇每1-SD与小动脉闭塞性卒中风险降低相关(OR 0.79;95%CI 0.67-0.90)(多变量MR)。
- 遗传升高的甘油三酯与缺血性卒中及其亚型无显著关联。
- MR-Egger显示无多效性偏倚,敏感性排除多效性单核苷酸多态性后结果未明显改变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Statin therapy is associated with a lower risk of ischemic stroke supporting a causal role of low-density lipoprotein (LDL) cholesterol. However, more evidence is needed to answer the question whether LDL cholesterol plays a causal role in ischemic stroke subtypes. In addition, it is unknown whether high-density lipoprotein cholesterol and triglycerides have a causal relationship to ischemic stroke and its subtypes. Our aim was to investigate the causal role of LDL cholesterol, high-density lipoprotein cholesterol, and triglycerides in ischemic stroke and its subtypes through Mendelian randomization (MR). METHODS: Summary data on 185 genome-wide lipids-associated single nucleotide polymorphisms were obtained from the Global Lipids Genetics Consortium and the Stroke Genetics Network for their association with ischemic stroke (n=16 851 cases and 32 473 controls) and its subtypes, including large artery atherosclerosis (n=2410), small artery occlusion (n=3186), and cardioembolic (n=3427) stroke. Inverse-variance-weighted MR was used to obtain the causal estimates. Inverse-variance-weighted multivariable MR, MR-Egger, and sensitivity exclusion of pleiotropic single nucleotide polymorphisms after Steiger filtering and MR-Pleiotropy Residual Sum and Outlier test were used to adjust for pleiotropic bias. RESULTS: A 1-SD genetically elevated LDL cholesterol was associated with an increased risk of ischemic stroke (odds ratio: 1.12; 95% confidence interval: 1.04-1.20) and large artery atherosclerosis stroke (odds ratio: 1.28; 95% confidence interval: 1.10-1.49) but not with small artery occlusion or cardioembolic stroke in multivariable MR. A 1-SD genetically elevated high-density lipoprotein cholesterol was associated with a decreased risk of small artery occlusion stroke (odds ratio: 0.79; 95% confidence interval: 0.67-0.90) in multivariable MR. MR-Egger indicated no pleiotropic bias, and results did not markedly change after sensitivity exclusion of pleiotropic single nucleotide polymorphisms. Genetically elevated triglycerides did not associate with ischemic stroke or its subtypes. CONCLUSIONS: LDL cholesterol lowering is likely to prevent large artery atherosclerosis but may not prevent small artery occlusion nor cardioembolic strokes. High-density lipoprotein cholesterol elevation may lead to benefits in small artery disease prevention. Finally, triglyceride lowering may not yield benefits in ischemic stroke and its subtypes.
引用
- Hindy G, Engström G, Larsson SC, et al. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study. Stroke. 2018. PMID: 29535274. doi:10.1161/STROKEAHA.117.019653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。